Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:05 pm Unchanged | 2024-11-14 | 13G | Cogent Biosciences, Inc. COGT | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-14 4:05 pm Unchanged | 2024-11-14 | 13G | Spyre Therapeutics, Inc. SYRE | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-14 4:05 pm Unchanged | 2024-11-14 | 13G | Adicet Bio, Inc. ACET | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-10-25 4:05 pm Unchanged | 2024-10-25 | 13G | Bright Minds Biosciences Inc. DRUG | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-10-17 4:05 pm Unchanged | 2024-10-17 | 13G | Inhibikase Therapeutics, Inc. IKT | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-06-21 4:05 pm Unchanged | 2024-06-21 | 13G | Perceptive Capital Solutions Corp Class A Ordinary Shares PCSC | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-04-19 4:05 pm Unchanged | 2024-04-19 | 13G | Perspective Therapeutics, Inc. CATX | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-03-21 4:05 pm Unchanged | 2024-03-21 | 13G | Definium Therapeutics, Inc. DFTX | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 4:10 pm Unchanged | 2024-02-14 | 13G | Vera Therapeutics, Inc. VERA | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 4:05 pm Unchanged | 2024-02-14 | 13G | Immunic, Inc. IMUX | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 4:05 pm Unchanged | 2024-02-14 | 13G | Adverum Biotechnologies, Inc. ADVM | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 4:05 pm Unchanged | 2024-02-14 | 13G | Cogent Biosciences, Inc. COGT | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 4:05 pm Unchanged | 2024-02-14 | 13G | CymaBay Therapeutics, Inc. CBAY | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 4:05 pm Unchanged | 2024-02-14 | 13G | Ambrx Biopharma Inc. AMAM | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 4:05 pm Unchanged | 2024-02-14 | 13G | Cabaletta Bio, Inc. CABA | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 4:05 pm Unchanged | 2024-02-14 | 13G | Celcuity Inc. CELC | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 4:05 pm Unchanged | 2024-02-14 | 13G | Soleno Therapeutics, Inc. SLNO | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 4:05 pm Unchanged | 2024-02-14 | 13G | Spyre Therapeutics, Inc. SYRE | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 4:05 pm Unchanged | 2024-02-14 | 13G | Enliven Therapeutics, Inc. ELVN | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-14 4:05 pm Unchanged | 2024-02-14 | 13G | Merus N.V. MRUS | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing |